High Growth Stocks With High Insider Ownership That Merit A Closer Look

Global oil prices are rallying on supply concerns tied to developments in the Strait of Hormuz. That keeps inflation risk alive and central banks wary of cutting rates quickly. Investors looking for growth may want companies that do not just rely on cheap money, but are driven by fast expanding businesses backed by committed insiders. This article highlights 3 stocks from the Fast Growing Stocks With High Insider Ownership screener.

The stocks below are just a small sample, and the full screen surfaced around 1,300 more companies with equally compelling growth stories and insider alignment that are not covered here. To go straight to the source, use the Fast Growing Stocks With High Insider Ownership screener to identify, filter, and analyze the highest conviction ideas for your watchlist.

Chime Financial (CHYM)

Overview: Chime Financial is a San Francisco based fintech that offers app based spending and savings accounts, debit cards, credit building tools and small dollar liquidity products to consumers in the United States and internationally, along with workplace financial benefits for employers.

Operations: Chime Financial generates all of its US$2.46b in revenue from data processing services, primarily in the United States.

Market Cap: US$11.83b

Chime Financial sits at the center of app based banking, with 9.1 million active members, rising Q2 2026 revenue of US$669.77 million and a recent return to GAAP profitability that caught analyst attention. The shift to its ChimeCore platform and higher margin products such as MyPay and instant loans is aimed at lifting gross margin and earnings. In addition, Chime Prime, Chime Invest and employer partnerships broaden how members use the account. At the same time, you need to weigh funding that relies on external borrowing rather than deposits, rising competition in fee free banking and sensitivity to interchange rules. For growth focused investors, the mix of payments revenue, higher value products and stronger guidance may warrant a closer look at this stock.

Chime Financial’s shift to higher margin products and GAAP profitability has many investors focused on the headline story, while the real growth engine sits in the analyst forecasts for Chime Financial that could reshape expectations.

Build your own high growth, high conviction shortlist

Chime Financial and the two other stocks in this list came from a single screener, but the real edge is in creating filters tuned to your own style. Use our flexible Screener to mix growth, valuation, quality and risk metrics into a custom watchlist, or start with one of our curated Investing Ideas.

AppLovin (APP)

Overview: AppLovin is a Palo Alto based company that runs an AI powered advertising platform, helping app developers, brands and content owners find and monetize users across mobile apps and connected TV through its Axon Ads Manager, MAX bidding system, Adjust analytics tools and Wurl streaming distribution network.

Market Cap: US$112.33b

AppLovin gives you exposure to AI driven advertising at scale, where strong margins, rapid earnings growth and a large share buyback program sit alongside a recent share price pullback after softer Q3 guidance and cautious analyst updates. The AXON platform, growing presence in e commerce and connected TV, and very high forecast Return on Equity suggest meaningful earnings power if advertiser spending on performance based campaigns continues to build. At the same time, heavy reliance on mobile gaming, tightening data privacy rules and intense competition from larger digital advertising companies keep risk firmly on the table. For growth investors, that mix of high quality profitability, valuation support and real regulatory and platform risks makes AppLovin a stock worth closer study.

AppLovin’s earnings engine and AI driven ad platform sit at the center of the story, yet the full picture only comes into focus when you see the 3 key rewards and 2 important warning signs that could explain what the recent pullback is really pricing in

BillionToOne (BLLN)

Overview: BillionToOne is a Menlo Park based precision diagnostics company that uses a molecular counting platform to detect and measure DNA at the single molecule level, helping clinicians assess fetal genetic risk and track cancer through blood based tests. Its key products include the UNITY non invasive prenatal screen, the Northstar Select liquid biopsy for tumor mutations, and Northstar Response for monitoring cancer burden over time.

Operations: BillionToOne generates all of its US$397 million in revenue from medical labs and research services in the United States.

Market Cap: US$4.32b

Investors looking at BillionToOne are getting exposure to prenatal screening and oncology testing where Q2 2026 revenue grew 64% year on year to a record level and gross margin sat above 70%, supported by strong uptake in UNITY prenatal tests and Northstar oncology assays. The business is already profitable and free cash flow positive. Analysts have highlighted the potential for further earnings expansion as reimbursement coverage widens and new features like Northstar Origin and MRD focused Northstar Response roll out. The catch is that oncology currently carries lower margins than prenatal and depends heavily on future Medicare coverage and ongoing clinical data, so results and sentiment can be volatile. The full story lies in how those high growth test volumes and margin trade offs play out from here.

BillionToOne’s rapid revenue growth and strong margins hint at a story that the market may not be fully pricing in. The real question is whether the current trajectory in prenatal and oncology testing is sustainable, and the analyst forecasts for BillionToOne could reveal the pressure points others are missing.

Seeking Fresh Alternatives Before Momentum Flies

Fresh ideas move first. By the time every investor spots a breakout, early momentum can be gone. Scan these under the radar lists before the crowd catches on and consider them while they are still overlooked.

• Target resilient compounding potential with a curated set of quality businesses from the list of solid balance sheet and fundamentals (49 results) and look for strength while prices still reflect hesitation.
• Study secular demand for critical materials through carefully filtered producers in the 8 top copper producer stocks and evaluate their positioning relative to potential supply constraints.
• Track cash generating AI-related companies with the 68 profitable AI stocks that aren't just burning cash and focus on businesses where revenue momentum is paired with discipline rather than frequent capital raising.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com